Skip to main content
padlock icon - secure page this page is secure

Tc99m Doped Nano-Hematite for Lung Photoscintigraphy

Buy Article:

$106.73 + tax (Refund Policy)

Spherical hematite (α-Fe2O3) particles of 30 nm diameter are prepared using the force hydrolysis method and tagged with Tc99m to form a phosphor material for lung imaging in the photoscintigraphic method. The size and shape of hematite sol is evaluated using dynamic and static laser light scattering. Nanosized Tc99m-hematite particles are inhaled by human volunteers using the aerosol/nebuliser and imaging is carried out using gamma camera. Very low dose of the radioactive Tc99m is required (2 milirads) in aerosol/nebuliser method as compared to intravenous injection method (20 milirads). Tc99m have lesser half life compared to colloidal Au198 therefore Tc99m-α-Fe2O3 colloids are safer than Au198 colloids. Due to less retention time in lung (as compared to micro- or bigger particles) and very low concentrations (than recommended minimum of 11 mg/day for daily uptake of iron or LD50 (oral, rat) = 30 gm/kg for pulmonary carcinogens), nano-hematite particles may assimilate easily in blood and avoid post-diagnostic side effects. High surface area to volume ratio of nano-sized α-Fe2O3 is useful to improve the delivery and imaging efficiency of radioactive particles in lung.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: LIGHT SCATTERING; LUNG SCINTIPHOTOGRAPHY; NANO-HEMATITE

Document Type: Research Article

Publication date: December 1, 2005

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more